| Literature DB >> 29898965 |
Joseph R Podojil1, Ming-Yi Chiang1, Igal Ifergan1, Ronald Copeland2, Linda N Liu2, Sebastien Maloveste2, Solomon Langermann2, David Liebenson3, Roumen Balabanov3, Hongbo Chi4, Lieping Chen5, Dario A A Vignali6,7, Stephen D Miller8.
Abstract
The potent immune regulatory function of an agonistic B7-H4-Ig fusion protein (B7-H4Ig) has been demonstrated in multiple experimental autoimmune models; however, the identity of a functional B7-H4 receptor remained unknown. The biological activity of B7-H4 is associated with decreased inflammatory CD4+ T cell responses as supported by a correlation between B7-H4-expressing tumor-associated macrophages and Foxp3+ T cells within the tumor microenvironment. Recent data indicate that members of the semaphorin (Sema)/plexin/neuropilin (Nrp) family of proteins both positively and negatively modulate immune cell function. In this study, we show that B7-H4 binds the soluble Sema family member Sema3a. Additionally, B7-H4Ig-induced inhibition of inflammatory CD4+ T cell responses is lost in both Sema3a functional mutant mice and mice lacking Nrp-1 expression in Foxp3+ T cells. These findings indicate that B7-H4Ig binds to Sema3a, which acts as a functional bridge to stimulate an Nrp-1/Plexin A4 heterodimer to form a functional immunoregulatory receptor complex resulting in increased levels of phosphorylated PTEN and enhanced regulatory CD4+ T cell number and function.Entities:
Mesh:
Substances:
Year: 2018 PMID: 29898965 PMCID: PMC6894186 DOI: 10.4049/jimmunol.1700811
Source DB: PubMed Journal: J Immunol ISSN: 0022-1767 Impact factor: 5.422